LabAutomation 2006 - SLAS
LabAutomation 2006 - SLAS LabAutomation 2006 - SLAS
MP07 Varouj Amirkhanian eGene, Inc. Irvine, California vamirkhanian@egeneinc.com Automated High-Speed Genetic Analyzer LabAutomation2006 Co-Author Ming-Sun Liu, eGene, Inc. We present a bench-type, high-performance and high-speed genetic analyzer, that uses cost-effective parallel multi-channel gel-capillary electrophoresis system with novel (patented) fluorescence type detection for bio-molecules analysis.12-DNA samples are automatically injected and analyzed simultaneously using a multiple usage and disposable multi-capillary (12-Channel) gel-cartridges. Using commercially available dsDNA size markers (i.e. FX174 DNA–Hae III digest dsDNA fragments) as indicators, the system provides high resolving power (
MP09 Alex Batchelor Cambrex Bio Science Nottingham Nottingham, United Kingdom alex.batchelor@cambrex.com Where Laboratory Technologies Emerge and Merge Co-Author(s) Lee Walker Anthony Pitt PDELight - A Novel, Generic and Simple High Throughput Assay for Screening cAMP-Dependent Phosphodiesterases In the cell phosphodiesterases (PDEs) function in conjunction with adenylate cyclases to regulate the amplitude of the ubiquitous 2nd messenger signalling molecule, cyclic adenosine monophosphate (cAMP). PDEs catalyze the hydrolysis of cAMP to adenosine monophosphate (AMP). There are at least 11 different families of PDEs most of which contain more than one isozyme. Their substrate specificities, kinetics and tissue specific expression make PDEs drugable targets for a range of diseases. A number of HTS assays are used to identify inhibitors of cAMP-PDEs. However these are either rad-based, require the use of beads, modified substrate or antibodies and are time consuming to perform. We introduce a novel luminescent HTS assay which offers a simple alternative to the current cAMP-PDE assays. The AMP produced from PDE hydrolysis of cAMP is quantified using a robust and highly sensitive luciferase-based luminescent reagent. The AMP is directly converted to ATP and quantified as light. Nearly a photon of light is emitted for every molecule of AMP produced. The assay is extremely simple to use and can be run in a number of ways to suit the user. Data represented in this study demonstrates the principle and performance of the assay. MP10 Michael Benedetti Buck Institute Novato, California mbenedetti@buckinstitute.org Co-Author(s) Matthew Gill Anders Olsen Amanda Foster Gordon Lithgow Development of High-Throughput Screens for Anti-Aging Compounds in the Nematode Caenorhabditis Elegans The nematode Caenorhabditis elegans provides an excellent model organism for investigating the aging process. These worms have a short lifespan of approximately 20 days and many single gene mutations have been found that more than double their lifespan. There is now considerable interest in identifying drugs that can influence nematode lifespan as they may provide novel therapeutic targets for amelioration of age related disease. Small scale, targeted screens have demonstrated that nematode lifespan can be increased by treatment with drugs such as anti-oxidants and anticonvulsants. It is likely that the development of high throughput screening methods will facilitate the discovery of many more compounds that are able to extend the lifespan of C. elegans. C. elegans is well suited to HTS as it is easy to grow large isogenic populations and maintain worms in multi-well plates. The use of an intact organism for the screening process also has many advantages over cell based assays. Most interventions that increase lifespan also increase resistance to acute stress. This makes it possible to assess the effect of a candidate compound within a few days using stress resistance assays as a surrogate for lifespan. Here we present different in vivo automated screens for compounds that affect survival following a stress. We discuss the results of small 2000 compound screens and show that the screens are adaptable to HTS. We discuss the hurdles to automating whole organism screens and their possible solutions. 107
- Page 58 and 59: LabAutomation2006 12:00 pm Tuesday,
- Page 60 and 61: LabAutomation2006 4:30 pm Tuesday,
- Page 62 and 63: LabAutomation2006 10:30 am Wednesda
- Page 64 and 65: LabAutomation2006 12:00 pm Monday,
- Page 66 and 67: LabAutomation2006 4:30 pm Monday, J
- Page 68 and 69: LabAutomation2006 12:00 pm Tuesday,
- Page 70 and 71: LabAutomation2006 4:30 pm Tuesday,
- Page 72 and 73: LabAutomation2006 10:30 am Wednesda
- Page 74 and 75: LabAutomation2006 12:00 pm Monday,
- Page 76 and 77: LabAutomation2006 4:30 pm Monday, J
- Page 78 and 79: LabAutomation2006 12:00 pm Tuesday,
- Page 80 and 81: LabAutomation2006 4:30 pm Tuesday,
- Page 82 and 83: LabAutomation2006 10:30 am Wednesda
- Page 84 and 85: LabAutomation2006 12:00 pm Monday,
- Page 86 and 87: LabAutomation2006 4:30 pm Monday, J
- Page 88 and 89: LabAutomation2006 12:00 pm Tuesday,
- Page 90 and 91: LabAutomation2006 4:30 pm Tuesday,
- Page 92 and 93: LabAutomation2006 10:30 am Wednesda
- Page 94 and 95: LabAutomation2006 12:00 pm Monday,
- Page 96 and 97: LabAutomation2006 4:30 pm Monday, J
- Page 98 and 99: LabAutomation2006 12:00 pm Tuesday,
- Page 100 and 101: LabAutomation2006 4:30 pm Tuesday,
- Page 102 and 103: LabAutomation2006 10:30 am Wednesda
- Page 104 and 105: Notes LabAutomation2006 102
- Page 106 and 107: MP03 Ismail Al-Abdulmohsen Saudi Ar
- Page 110 and 111: MP11 Sibani Biswal University of Be
- Page 112 and 113: MP15 Josh Eckman University of Utah
- Page 114 and 115: MP19 Ismet Celebi National Institut
- Page 116 and 117: MP23 Robin Clark deCODE Biostructur
- Page 118 and 119: MP27 J. Colin Cox Duke University M
- Page 120 and 121: MP31 Frank Doffing IMM - Institut f
- Page 122 and 123: MP35 Aoife Gallagher Deerac Fluidic
- Page 124 and 125: MP39 Yunseok Heo University of Mich
- Page 126 and 127: MP43 David Humphries Lawrence Berke
- Page 128 and 129: MP47 Joohoon Kim University of Texa
- Page 130 and 131: MP51 Michelle Li Saint Louis Univer
- Page 132 and 133: MP55 Philip Manning Procter & Gambl
- Page 134 and 135: MP59 Irena Nikcevic University of C
- Page 136 and 137: MP63 Qiaosheng Pu Virginia Commonwe
- Page 138 and 139: MP67 Alexander Roth National Instit
- Page 140 and 141: MP71 Sang Jun Son University of Mar
- Page 142 and 143: MP75 Lois Tack PerkinElmer Life & A
- Page 144 and 145: MP79 Angelo Trivelli J Craig Venter
- Page 146 and 147: MP83 Tracy Worzella Promega Corpora
- Page 148 and 149: MP87 Peter Greenhalgh Astech Projec
- Page 150 and 151: MP91 David Ferrick Seahorse Bioscie
- Page 152 and 153: MP95 Christine Brideau Merck Frosst
- Page 154 and 155: TP01 Marc Pfeifer Roche Molecular S
- Page 156 and 157: TP05 Marcy Engelstein Millipore Cor
MP07<br />
Varouj Amirkhanian<br />
eGene, Inc.<br />
Irvine, California<br />
vamirkhanian@egeneinc.com<br />
Automated High-Speed Genetic Analyzer<br />
<strong>LabAutomation</strong><strong>2006</strong><br />
Co-Author<br />
Ming-Sun Liu, eGene, Inc.<br />
We present a bench-type, high-performance and high-speed genetic analyzer, that uses cost-effective parallel multi-channel gel-capillary<br />
electrophoresis system with novel (patented) fluorescence type detection for bio-molecules analysis.12-DNA samples are automatically<br />
injected and analyzed simultaneously using a multiple usage and disposable multi-capillary (12-Channel) gel-cartridges. Using commercially<br />
available dsDNA size markers (i.e. FX174 DNA–Hae III digest dsDNA fragments) as indicators, the system provides high resolving power<br />
(